Pacira BioSciences, Inc.
PCRX
$23.04
$0.200.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 78.13% | -69.86% | 212.07% | -200.73% | -70.00% |
| Total Depreciation and Amortization | -20.53% | 71.07% | -42.57% | 29.07% | -0.35% |
| Total Amortization of Deferred Charges | 0.17% | -15.54% | -21.79% | 0.58% | -0.12% |
| Total Other Non-Cash Items | 17,116.44% | -100.13% | 104.80% | 390.45% | -53.93% |
| Change in Net Operating Assets | -178.64% | 191.95% | 58.13% | -1,318.95% | 118.53% |
| Cash from Operations | -41.22% | -28.18% | 406.44% | -66.12% | 7.02% |
| Capital Expenditure | -1,149.54% | 94.37% | -43.49% | 68.45% | -303.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.08% | -58.83% | -26.79% | 17,213.46% | -121.66% |
| Cash from Investing | 0.56% | -55.67% | -29.84% | 342.55% | -6,864.40% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 0.00% | 98.37% | -8,066.29% | -33.31% | -0.04% |
| Issuance of Common Stock | -99.88% | 14,250.00% | -99.24% | -- | -- |
| Repurchase of Common Stock | -12.42% | 3.31% | 9.53% | -30,465.75% | -135.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.77% | -- | -- | -- |
| Cash from Financing | -15.00% | 79.94% | -347.75% | -1,820.67% | -53.15% |
| Foreign Exchange rate Adjustments | 109.18% | -411.28% | -34.80% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -229.97% | 107.17% | -1,006.10% | 146.84% | -77.81% |